245 related articles for article (PubMed ID: 17314297)
1. Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis.
Balabanov R; Strand K; Goswami R; McMahon E; Begolka W; Miller SD; Popko B
J Neurosci; 2007 Feb; 27(8):2013-24. PubMed ID: 17314297
[TBL] [Abstract][Full Text] [Related]
2. Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
Stone S; Wu S; Jamison S; Durose W; Pallais JP; Lin W
Glia; 2018 Jul; 66(7):1331-1345. PubMed ID: 29436030
[TBL] [Abstract][Full Text] [Related]
3. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.
Lin W; Lin Y; Li J; Fenstermaker AG; Way SW; Clayton B; Jamison S; Harding HP; Ron D; Popko B
J Neurosci; 2013 Apr; 33(14):5980-91. PubMed ID: 23554479
[TBL] [Abstract][Full Text] [Related]
4. Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma.
Balabanov R; Strand K; Kemper A; Lee JY; Popko B
J Neurosci; 2006 May; 26(19):5143-52. PubMed ID: 16687505
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Loda E; Balabanov R
Rev Neurosci; 2012 Jan; 23(2):145-52. PubMed ID: 22499673
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
Tran EH; Prince EN; Owens T
J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
[TBL] [Abstract][Full Text] [Related]
7. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
8. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Src-suppressed C kinase substrate in experimental autoimmune encephalomyelitis: a link between release of astrocyte proinflammatory factor and oligodendrocyte apoptosis.
Li X; Yan M; Hu L; Sun L; Zhang F; Ji H; Jiang J; Wang P; Liu H; Gao Y; Tao T; He X; Cheng C; Shen A
J Neurosci Res; 2010 Jul; 88(9):1858-71. PubMed ID: 20155814
[TBL] [Abstract][Full Text] [Related]
10. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
11. Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation.
Boghozian R; McKenzie BA; Saito LB; Mehta N; Branton WG; Lu J; Baker GB; Noorbakhsh F; Power C
Glia; 2017 Oct; 65(10):1590-1606. PubMed ID: 28707358
[TBL] [Abstract][Full Text] [Related]
12. Absence of IFN-γ increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the central nervous system.
Mangalam AK; Luo N; Luckey D; Papke L; Hubbard A; Wussow A; Smart M; Giri S; Rodriguez M; David C
J Immunol; 2014 Nov; 193(10):4859-70. PubMed ID: 25339670
[TBL] [Abstract][Full Text] [Related]
13. Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation.
Valentin-Torres A; Savarin C; Barnett J; Bergmann CC
J Neuroinflammation; 2018 Apr; 15(1):121. PubMed ID: 29690885
[TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte-Specific Deletion of
Rajendran R; Rajendran V; Giraldo-Velasquez M; Megalofonou FF; Gurski F; Stadelmann C; Karnati S; Berghoff M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502405
[TBL] [Abstract][Full Text] [Related]
15. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis.
Garay LI; González Deniselle MC; Brocca ME; Lima A; Roig P; De Nicola AF
Neuroscience; 2012 Dec; 226():40-50. PubMed ID: 23000619
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
Furlan R; Brambilla E; Ruffini F; Poliani PL; Bergami A; Marconi PC; Franciotta DM; Penna G; Comi G; Adorini L; Martino G
J Immunol; 2001 Aug; 167(3):1821-9. PubMed ID: 11466408
[TBL] [Abstract][Full Text] [Related]
17. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
Carter SL; Müller M; Manders PM; Campbell IL
Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
[TBL] [Abstract][Full Text] [Related]
18. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma regulates oxidative stress during experimental autoimmune encephalomyelitis.
Espejo C; Penkowa M; Sáez-Torres I; Hidalgo J; García A; Montalban X; Martínez-Cáceres EM
Exp Neurol; 2002 Sep; 177(1):21-31. PubMed ID: 12429207
[TBL] [Abstract][Full Text] [Related]
20. Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-β.
Jana M; Mondal S; Gonzalez FJ; Pahan K
J Biol Chem; 2012 Oct; 287(41):34134-48. PubMed ID: 22879602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
